Сlinical Trials

The CureLab Oncology team has completed its international Phase I/IIa Clinical Trials of Elenagen™. The vaccine demonstrated a high degree of safety as well as clinical benefits in a number of patients. Based on these successful results, we initiated Phase II Clinical Trials outside of the United States, and are now preparing Phase II Clinical Trials within the US.
 

Completed phase I/IIa clinical trial

Twenty-seven patients participated in phase I/IIa clinical trials conducted in 4 different clinical centers in Russia.

Elenagen™: Case Study

International Clinical Trials 2019

2019. Phase II clinical trials in Belarus and Brazil.
Randomized case-control phase II clinical studies
The goal: to test the ability of Elenagen™ to enhance standards of care for
  • Triple negative breast cancer
  • Ovarian cancer
  • Inoperable stomach cancer
  • Pancreatic cancer
Observation by the leading US medical centers
Pending future international clinical trials in
  • Glioblastoma
  • Metastatic hormone-resistant prostate cancer
  • Metastatic renal cancer
  • Metastatic uterus cancer
  • Melanoma

US clinical trials

Anticipated to begin in 2020

The goal: to test the ability of Elenagen™ to enhance standards of care for

  • Triple negative breast cancer
  • Ovarian cancer

For any inquiries, please contact: info@curelab.com